Cite
SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia
MLA
Mar, Brenton G., et al. “SETD2 Alterations Impair DNA Damage Recognition and Lead to Resistance to Chemotherapy in Leukemia.” Blood, vol. 130, no. 24, Dec. 2017, pp. 2631–41. EBSCOhost, https://doi.org/10.1182/blood-2017-03-775569.
APA
Mar, B. G., Chu, S. H., Kahn, J. D., Krivtsov, A. V., Koche, R., Castellano, C. A., Kotlier, J. L., Zon, R. L., McConkey, M. E., Chabon, J., Chappell, R., Grauman, P. V., Hsieh, J. J., Armstrong, S. A., & Ebert, B. L. (2017). SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia. Blood, 130(24), 2631–2641. https://doi.org/10.1182/blood-2017-03-775569
Chicago
Mar, Brenton G., S. Haihua Chu, Josephine D. Kahn, Andrei V. Krivtsov, Richard Koche, Cecilia A. Castellano, Jacob L. Kotlier, et al. 2017. “SETD2 Alterations Impair DNA Damage Recognition and Lead to Resistance to Chemotherapy in Leukemia.” Blood 130 (24): 2631–41. doi:10.1182/blood-2017-03-775569.